Reader View AI Reader View Stock Market Today, Nov. 18: Recursion Pharmaceuticals Rises 4% on FDA Alignment for REC-4881 Phase 3 Design www.nasdaq.com · November 18, 2026 · 22:40 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link